Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.88B
Enterprise Value2.79B
P/E Ratio124.31
PEG Ratio-11.3
Price/Sales Ratio5.11
Price/Book Ratio5.16
Enterprise/Revenue5.04
Enterprise/EBITDA36.08

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.04

Income Statement

Revenue877.85M
Revenue/Share2.38
Gross Profit584.11M
EBITDA126.91M
Net Income43.95M
Diluted EPS0.14

Balance Sheet

Total Cash169.22M
Total Cash/Share0.56
Total Debt123.62M
Total Debt/Equity0.17
Current Ratio1.65
Book Value Per Share2.8

Price History

52-Week Change20.73
52-Week High20.96
52-Week Low6.78
Moving Average 50 Days13.66
Moving Average 200 Days10.39

Statistics

Average Volume57.96M
Shares Outstanding303.35M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.04
Trailing Annual Dividend Yield0.33
Payout Ratio0.05
Last Split Factor7:2
Last Split DateMay 10, 2017
AD